DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Breast Cancer Patients

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
DiviTum®TKa: A Biomarker Assay for Efficacy in HR+ Breast Cancer Patients	Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder	Recruiting	Not stated	2026-06-01		NCT06388122

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Mayo Clinic	970

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Mayo Clinic in Florida	Jacksonville	United States	224

Clinical trials